168 related articles for article (PubMed ID: 15711593)
1. Antisecretory actions of a novel vasoactive intestinal polypeptide (VIP) antagonist in human and rat small intestine.
Banks MR; Farthing MJ; Robberecht P; Burleigh DE
Br J Pharmacol; 2005 Apr; 144(7):994-1001. PubMed ID: 15711593
[TBL] [Abstract][Full Text] [Related]
2. VPAC1 receptors regulate intestinal secretion and muscle contractility by activating cholinergic neurons in guinea pig jejunum.
Fung C; Unterweger P; Parry LJ; Bornstein JC; Foong JP
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G748-58. PubMed ID: 24578344
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal polypeptide receptor VPAC(1) subtype is predominant in rat prostate membranes.
Juarranz MG; De Neef P; Robberecht P
Prostate; 1999 Sep; 41(1):1-6. PubMed ID: 10440869
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro.
Baldassano S; Wang GD; Mulè F; Wood JD
Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(3):G352-8. PubMed ID: 22075777
[TBL] [Abstract][Full Text] [Related]
5. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L; Ahrén B; Edgren G; Degerman E
Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
[TBL] [Abstract][Full Text] [Related]
6. Effect of vasoactive intestinal polypeptide (VIP) antagonism on rat jejunal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins.
Mourad FH; Nassar CF
Gut; 2000 Sep; 47(3):382-6. PubMed ID: 10940276
[TBL] [Abstract][Full Text] [Related]
7. Xenin-25 induces anion secretion by activating noncholinergic secretomotor neurons in the rat ileum.
Kuwahara A; Kuwahara Y; Kato I; Kawaguchi K; Harata D; Asano S; Inui T; Marunaka Y
Am J Physiol Gastrointest Liver Physiol; 2019 Jun; 316(6):G785-G796. PubMed ID: 30978113
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide (VIP) stimulates cortisol secretion from the H295 human adrenocortical tumour cell line via VPAC1 receptors.
Nicol MR; Cobb VJ; Williams BC; Morley SD; Walker SW; Mason JI
J Mol Endocrinol; 2004 Jun; 32(3):869-77. PubMed ID: 15171718
[TBL] [Abstract][Full Text] [Related]
9. Lack of effect of three putative vasoactive intestinal peptide receptor antagonists on vasoactive intestinal peptide-induced secretory responses in rat colon.
Burleigh DE; Kirkham SE
Eur J Pharmacol; 1993 Nov; 249(2):239-42. PubMed ID: 8287907
[TBL] [Abstract][Full Text] [Related]
10. Effects of vasoactive intestinal polypeptide on neurones of the rat suprachiasmatic nuclei in vitro.
Reed HE; Cutler DJ; Brown TM; Brown J; Coen CW; Piggins HD
J Neuroendocrinol; 2002 Aug; 14(8):639-46. PubMed ID: 12153466
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal polypeptide regulates barrier function via mast cells in human intestinal follicle-associated epithelium and during stress in rats.
Keita AV; Carlsson AH; Cigéhn M; Ericson AC; McKay DM; Söderholm JD
Neurogastroenterol Motil; 2013 Jun; 25(6):e406-17. PubMed ID: 23600853
[TBL] [Abstract][Full Text] [Related]
12. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
Goursaud S; Pineau N; Becq-Giraudon L; Gressens P; Muller JM; Janet T
J Neuroimmunol; 2005 Jan; 158(1-2):94-105. PubMed ID: 15589042
[TBL] [Abstract][Full Text] [Related]
13. Neurogenic secretion mediated by the purinergic P2Y1 receptor in guinea-pig small intestine.
Fang X; Hu HZ; Gao N; Liu S; Wang GD; Wang XY; Xia Y; Wood JD
Eur J Pharmacol; 2006 Apr; 536(1-2):113-22. PubMed ID: 16566916
[TBL] [Abstract][Full Text] [Related]
14. In vitro properties of a high affinity selective antagonist of the VIP1 receptor.
Gourlet P; De Neef P; Cnudde J; Waelbroeck M; Robberecht P
Peptides; 1997; 18(10):1555-60. PubMed ID: 9437716
[TBL] [Abstract][Full Text] [Related]
15. A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects.
Summers MA; O'Dorisio MS; Cox MO; Lara-Marquez M; Goetzl EJ
J Pharmacol Exp Ther; 2003 Aug; 306(2):638-45. PubMed ID: 12750439
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2).
Anderson CM; Mendoza ME; Kennedy DJ; Raldua D; Thwaites DT
Br J Pharmacol; 2003 Feb; 138(4):564-73. PubMed ID: 12598410
[TBL] [Abstract][Full Text] [Related]
17. Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine.
Jayawardena D; Guzman G; Gill RK; Alrefai WA; Onyuksel H; Dudeja PK
Am J Physiol Gastrointest Liver Physiol; 2017 Jul; 313(1):G16-G25. PubMed ID: 28385693
[TBL] [Abstract][Full Text] [Related]
18. Activation of VPAC1 receptors by VIP and PACAP-27 in human bronchial epithelial cells induces CFTR-dependent chloride secretion.
Dérand R; Montoni A; Bulteau-Pignoux L; Janet T; Moreau B; Muller JM; Becq F
Br J Pharmacol; 2004 Feb; 141(4):698-708. PubMed ID: 14744818
[TBL] [Abstract][Full Text] [Related]
19. Endogenous inhibition of hippocampal LTD and depotentiation by vasoactive intestinal peptide VPAC1 receptors.
Cunha-Reis D; Aidil-Carvalho Mde F; Ribeiro JA
Hippocampus; 2014 Nov; 24(11):1353-63. PubMed ID: 24935659
[TBL] [Abstract][Full Text] [Related]
20. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
